These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11788235)

  • 21. Endogenous sodium pump inhibition: current status and therapeutic opportunities.
    Hollenberg NK; Graves SW
    Prog Drug Res; 1996; 46():9-42. PubMed ID: 8754202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Digitalis receptor].
    Rey HG; Anner BM
    Schweiz Med Wochenschr; 1987 Nov; 117(48):1881-7. PubMed ID: 2827301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous digitalis: reality or myth?
    Goto A; Yamada K; Sugimoto T
    Life Sci; 1991; 48(22):2109-18. PubMed ID: 1851919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous digitalis-like factors. An historical overview.
    Buckalew VM
    Front Biosci; 2005 Sep; 10():2325-34. PubMed ID: 15970498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.
    Mahon N; Mckenna WJ
    Eur Heart J; 2000 Jul; 21(13):1034-6. PubMed ID: 10843817
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes and simulated weightlessness in rats.
    Pamnani MB; Chen S; Haddy FJ; Yuan C; Mo Z
    Clin Exp Hypertens; 1998; 20(5-6):509-21. PubMed ID: 9682907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidigoxin antiserum prevents endogenous digitalis-like compound-mediated reperfusion injury via modulating sodium pump isoform gene expression.
    Wang HG; Chu YF; Zou JG; Ke YS
    Can J Physiol Pharmacol; 2010 Jan; 88(1):38-44. PubMed ID: 20130737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity and lability of endogenous digitalis-like substances in the plasma of the toad, Bufo marinus.
    Butler VP; Morris JF; Akizawa T; Matsukawa M; Keating P; Hardart A; Furman I
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R325-32. PubMed ID: 8770130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of erythrocyte Na,K-ATPase activity during anticipatory hypoventilation in micropigs.
    Fedorova OV; French AW; Anderson DE
    Am J Hypertens; 1996 Nov; 9(11):1126-31. PubMed ID: 8931839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of an endogenous digitalis-like factor in human newborn plasma. Effects on rat (Na+/K+)-ATPase isoforms and on binding to placenta.
    Crambert G; Balzan S; Paci A; Decollogne S; Montali U; Ghione S; Lelièvre LG
    Ann N Y Acad Sci; 1997 Nov; 834():621-5. PubMed ID: 9405874
    [No Abstract]   [Full Text] [Related]  

  • 36. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
    Tao QF; Soszynski PA; Hollenberg NK; Graves SW
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium pump isoform specificity for digitalis-like factor.
    Ferrari P
    Hypertension; 1997 Nov; 30(5):1296-7. PubMed ID: 9369292
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue distribution of an endogenous ligand to the Na, K ATPase molecule.
    Rauch AL; Buckalew VM
    Biochem Biophys Res Commun; 1988 Apr; 152(2):818-24. PubMed ID: 2835043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endogenous digitalis-like factor.
    Kölbel F; Schreiber V
    Mol Cell Biochem; 1996; 160-161():111-5. PubMed ID: 8901463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.